EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?

Martina Ricci, Gianpaolo Cicala, Anna Capasso, Giorgia Coratti iD, Stefania Fiori, Costanza Cutrona, Adele D'Amico iD, Valeria A Sansone, Claudio Bruno, Sonia Messina, Tiziana Mongini, Michela Coccia und 25 weitere

Annals of Neurology · 2023

DOI: 10.1002/ana.26788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2023. Verfasst von Martina Ricci und 36 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neurology, Università Cattolica del Sacro Cuore, Rome, Italy. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Biogen, Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this study was to provide an overview of the clinical phenotypes associated with 4 SMN2 copies.

Methods

Clinical phenotypes were analyzed in all the patients with 4 SMN2 copies as part of a nationwide effort including all the Italian pediatric and adult reference centers for spinal muscular atrophy (SMA).

Results

The cohort includes 169 patients (102 men and 67 women) with confirmed 4 SMN2 copies (mean age at last follow‐up = 36.9 ± 19 years). Six of the 169 patients were presymptomatic, 8 were classified as type II, 145 as type III (38 type IIIA and 107 type IIIB), and 8 as type IV. The remaining 2 patients were asymptomatic adults identified because of a familial case. The cross‐sectional functional data showed a reduction of scores with increasing age. Over 35% of the type III and 25% of the type IV lost ambulation (mean age = 26.8 years ± 16.3 SD). The risk of loss of ambulation was significantly associated with SMA type ( p < 0.0001), with patients with IIIB and IV less likely to lose ambulation compared to type IIIA. There was an overall gender effect with a smaller number of women and a lower risk for women to lose ambulation. This was significant in the adult ( p = 0.009) but not in the pediatric cohort ( p = 0.43).

Interpretation

Our results expand the existing literature on natural history of 4 SMN2 copies confirming the variability of phenotypes in untreated patients, ranging from type II to type IV and an overall reduction of functional scores with increasing age. ANN NEUROL 2023;94:1126–1135

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Atrophy, SpinalMaleAdultChildHumansFemaleAdolescentYoung AdultMiddle AgedCross-Sectional StudiesPhenotypeWalkingSurvival of Motor Neuron 1 ProteinSurvival of Motor Neuron 2 Protein

Substanzen

Survival of Motor Neuron 1 ProteinSMN2 protein, humanSurvival of Motor Neuron 2 Protein

Autor:innen und Institutionen

  • Pediatric Neurology, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Centro Clinico Nemo, Fondazione Agostino Gemelli IRCCS, Rome, Italy.
  • Department of Life Sciences and Public Health, Section of Genomic Medicine, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Department of Neurosciences, Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • The NEMO Center in Milan, Neurorehabilitation Unit, University of Milan, ASST Niguarda Hospital, Milan, Italy.
  • Center of Translational and Experimental Myology, and Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, IRCCS Istituto Giannina Gaslini, Genova, Italy.

ORCID-Profile: Giorgia Coratti, Adele D'Amico, Massimiliano Filosto, Giacomo P Comi, Stefania Corti, Dario Ronchi, Lucia Ruggiero, Matteo Garibaldi, Francesco Danilo Tiziano, Eugenio Mercuri

Förderung

  • Biogen
  • Roche

Zitieren

APA

Ricci, M., Cicala, G., Capasso, A., Coratti, G., Fiori, S., Cutrona, C., D'Amico, A., Sansone, V. A., Bruno, C., Messina, S., Mongini, T., Coccia, M., Siciliano, G., Pegoraro, E., Masson, R., Filosto, M., Comi, G. P., Corti, S., Ronchi, D., …, & ITASMAC Working Group (2023). Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?. Annals of Neurology. https://doi.org/10.1002/ana.26788

Vancouver

Ricci M, Cicala G, Capasso A, Coratti G, Fiori S, Cutrona C, et al. Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?. Annals of Neurology. 2023. doi:10.1002/ana.26788

BibTeX
@article{Ricci2023,
  author = {Ricci, Martina and Cicala, Gianpaolo and Capasso, Anna and Coratti, Giorgia and Fiori, Stefania and Cutrona, Costanza and D'Amico, Adele and Sansone, Valeria A and Bruno, Claudio and Messina, Sonia and Mongini, Tiziana and Coccia, Michela and Siciliano, Gabriele and Pegoraro, Elena and Masson, Riccardo and Filosto, Massimiliano and Comi, Giacomo P and Corti, Stefania and Ronchi, Dario and Maggi, Lorenzo and D'Angelo, Maria G and Vacchiano, Veria and Ticci, Chiara and Ruggiero, Lucia and Verriello, Lorenzo and Ricci, Federica S and Berardinelli, Angela L and Maioli, Maria Antonietta and Garibaldi, Matteo and Nigro, Vincenzo and Previtali, Stefano C and Pera, Maria Carmela and Tizzano, Eduardo and Pane, Marika and Tiziano, Francesco Danilo and Mercuri, Eugenio and ITASMAC Working Group, ITASMAC Working Group},
  title = {Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?},
  journal = {Annals of Neurology},
  year = {2023},
  doi = {10.1002/ana.26788}
}
Kostenlos starten →